- Benzinga•14 hours ago
Biotech is one of the sectors where M&A activities never stop, as the potential for growth and development is immense. After the termination of a $160 billion merger with Allergan plc Ordinary Shares (NYSE: ...
- Insider Monkey•2 days ago
Given the immense size of the broader market and the relatively small number of funds in our database (not to mention we don’t track many mutual funds or other gargantuan investment vehicles), the collection of funds that we track typically don’t have ownership of more than 20% of any given stock. In the instance of Herbalife Ltd. […]
- Benzinga•3 days agoJanney Initiates Jazz Pharma At Neutral, Cites Potential Competition For 'Blockbuster Narcolepsy Franchise'
Janney started coverage of Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ: JAZZ ) with a Neutral rating, citing potential competition to its blockbuster narcolepsy franchise. Jazz's history was based ...
Jazz Pharmaceuticals Public Limited Company (JAZZ)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||109.11 x 100|
|Ask||138.00 x 500|
|Day's Range||126.90 - 129.64|
|52wk Range||108.50 - 173.79|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||22.59|
|Avg Vol (3m)||782,796|
|Dividend & Yield||N/A (N/A)|